CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Exact Sciences Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Exact Sciences Corp
5505 Endeavor Lane
Phone: (608) 284-5700p:608 284-5700 MADISON, WI  53719  United States Ticker: EXASEXAS
Business Summary
Exact Sciences Corporation is a global advanced cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The Company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening, MCED Test Development and MRD Test Development. The Company’s products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, and OncoExTra Test. The Company’s flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes--Yes

Industries
SIC Code Description
8731 Commercial physical and biological research
2835 In vitro and in vivo diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer Kevin T.Conroy 58 3/21/2014 3/1/2009
Chief Financial Officer AaronBloomer 38 5/15/2024 4/15/2024
Executive Vice President, General Manager - Precision Oncology BrianBaranick 46 12/1/2023 7/1/2022
9 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Ashion Analytics, LLC 445 North 5th Street Phoenix AZ United States
Genomic Health, Inc. 301 Penobscot Drive Redwood City CA United States
Biomatrica, Inc. 5627 Oberlin Dr San Diego CA United States
Thrive Earlier Detection Corp. 222 Jacobs Street Cambridge MA United States
PreventionGenetics 3800 S Business Park Ave. Marshfield WI United States

Business Names
Business Name
Armune BioScience, Inc.
Ashion Analytics, LLC
Base Genomics
7 additional Business Names available in full report.

General Information
Number of Employees: 6,500 (As of 12/31/2023)
Outstanding Shares: 185,076,293 (As of 11/4/2024)
Shareholders: 179
Stock Exchange: NASD
Federal Tax Id: 020478229
Fax Number: (608) 284-5701
Email Address: info@exactsciences.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024